Jinyu Bio-technology Co., Ltd. (SHA:600201)
15.09
+0.22 (1.48%)
May 8, 2026, 3:00 PM CST
Jinyu Bio-technology Market Cap
Jinyu Bio-technology has a market cap or net worth of 16.49 billion as of May 8, 2026. Its market cap has increased by 115.81% in one year.
Market Cap
16.49B
Enterprise Value
15.29B
Revenue
1.39B
Ranking
n/a
PE Ratio
167.67
Stock Price
15.09
Market Cap Chart
Since January 18, 1999, Jinyu Bio-technology's market cap has increased from 977.52M to 16.49B, an increase of 1,586.86%. That is a compound annual growth rate of 10.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 16.49B | 0.13% |
| Dec 31, 2025 | 16.47B | 114.89% |
| Dec 31, 2024 | 7.66B | -34.56% |
| Dec 29, 2023 | 11.71B | 18.94% |
| Dec 30, 2022 | 9.85B | -46.16% |
| Dec 31, 2021 | 18.29B | -22.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Yili Chuanning Biotechnology | 22.26B |
| Sinocelltech Group | 20.16B |
| Mabwell (Shanghai) Bioscience | 15.26B |
| Anhui Anke Biotechnology (Group) | 14.65B |
| Chengdu Olymvax Biopharmaceuticals | 14.20B |
| Chengzhi | 13.95B |
| Staidson (Beijing) BioPharmaceuticals | 13.69B |
| Inner Mongolia Furui Medical Science | 13.62B |